RC-552

• Description :

  RC-552 is a novel synthetic glycolipid related in chemical structure to MLA. RC-552 induces delayed cardioprotective effects via an iNOS-dependent pathway. RC-552 attenuates myocardial stunning[1][2].

• UNSPSC :

  12352005

• Target :

  NO Synthase

• Related Pathways :

  Immunology/Inflammation

• Field of Research :

  Cardiovascular Disease

• Smiles :

  CCCCCCCCCCCCCC(O[C@H](CCCCCCCCCCC)CC(O[C@@H]1[C@H]([C@@H](O[C@H](CO)[C@H]1OP(O)(O)=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCCCC)=O)=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCCCCCC)=O)=O)=O)=O

• Molecular Formula :

  C102H193N2O21P

• Molecular Weight :

  1814.60

• References & Citations :

  [1]Elliott GT, et al. The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. J Mol Cell Cardiol. 2000 Jul;32 (7) :1327-39. |[2]Xi L, et al. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Am J Physiol. 1999 Dec;277 (6) :H2418-24.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [253119-91-4]